EUVIMEDEUVIMED entdecken
Crossref

Authors’ response to: SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence

Katarzyna Joanna Jakuszko, Sławomir Cezary Zmonarski, Mirosław Adam Banasik

Clinical Diabetology · 20.07.2026

DOI: 10.5603/cd.112501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Diabetology, online erschienen am 20.07.2026. Verfasst von Katarzyna Joanna Jakuszko und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jakuszko, K. J., Zmonarski, S. C., & Banasik, M. A. (2026). Authors’ response to: SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. https://doi.org/10.5603/cd.112501

Vancouver

Jakuszko KJ, Zmonarski SC, Banasik MA. Authors’ response to: SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. 2026. doi:10.5603/cd.112501

BibTeX
@article{Jakuszko2026,
  author = {Jakuszko, Katarzyna Joanna and Zmonarski, Sławomir Cezary and Banasik, Mirosław Adam},
  title = {Authors’ response to: SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence},
  journal = {Clinical Diabetology},
  year = {2026},
  doi = {10.5603/cd.112501}
}
Kostenlos starten →